Subscribe
Subscribe
MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
Logo IMG
HOME > MULTIMEDIA > Multimedia Detail

SCIENCE IN THE NEWS DAILY

Erbitux OK for Colorectal Cancer Patients with Genetic Marker

from USA Today

A new study shows which colorectal cancer patients may benefit from a drug - and which would be better off without it.

The drug Erbitux doesn't work in patients whose tumor has a certain genetic mutation, according to a study of nearly 600 patients, presented Sunday at the annual meeting of the American Society of Clinical Oncology in Chicago.

About 36 percent of patients in the study have the mutation, in a gene called KRAS, says co-author Eric Van Cutsem, of University Hospital Gasthuisberg in Belgium. All of the patients in the study had colorectal cancer that had spread to other organs.

Read more ...


comments powered by Disqus
 

Connect With Us:

Facebook Icon Sm Twitter Icon Google+ Icon Pinterest Icon RSS Feed Instagram Icon

Latest Multimedia

KosowskyImage1Click to Enlarge Image

PODCASTS: Expanding With the Cosmos

Using the Atacama Cosmology Telescope (ATC), a 6.5-meter microwave collector in Chile, cosmologists are piecing together the early history of the known universe. In an exclusive American Scientist interview, Arthur Kosowsky—a member of the ATC team and a professor in the Department of Physics and Astronomy at the University of Pittsburgh—discusses how he is using ATC to reach back in time billions of years to search for gravitational waves that could verify inflation and reveal unprecedented details about how the cosmos was born.

To view all multimedia content, click "Latest Multimedia."



RSS Feed Subscription

Receive notification when new content is posted from the entire website, or choose from the customized feeds available.


EMAIL TO A FRIEND :

Of Possible Interest

Science In The News Daily: Diesel Exhausts Do Cause Cancer, Says WHO

Science in the News Weekly: T-DM1 Treats Breast Cancer With Fewer Side Effects

Science In The News Daily: CT Scans on Children 'Could Triple Brain Cancer Risk'

Subscribe to American Scientist